MMP-3 (5A/6A) polymorphism does not influence human smooth muscle cell invasion

Journal of Surgical Research

Volumn 175, Issue 2, 2012, Pages 343-349

  Maqbool, Azhar ^a   Keswani, Anita ^a   Galloway, Stacey ^a   O'Regan, David J ^b,c   Ball, Stephen G ^a,b   Turner, Neil A ^a,b   Porter, Karen E ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

human; invasion; MMP 3; polymorphism; saphenous vein; smooth muscle cell

Indexed keywords

INTERLEUKIN 1; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BB; STROMELYSIN;

ADULT; ARTICLE; CELL CULTURE; CELL INVASION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; PROTEIN SECRETION; SMOOTH MUSCLE FIBER;

AGED; ALLELES; CELL MOVEMENT; CELLS, CULTURED; COHORT STUDIES; CORONARY ARTERY BYPASS; GENOTYPE; GRAFT REJECTION; HUMANS; INTERLEUKIN-1; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; PLATELET-DERIVED GROWTH FACTOR; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; UP-REGULATION; VASCULAR GRAFTING;

EID: 84860703739     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.03.043     Document Type: Article

References (40)

1. H. Suma Arterial grafts in coronary bypass surgery Ann Thorac Cardiovasc Surg 5 1999 141
2. A.C. Newby Matrix metalloproteinases regulate migration, proliferation and death of vascular smooth muscle cells by degrading matrix and non matrix substrates Cardiovasc Res 69 2006 614
3. H.R. Lijnen Extracellular proteolysis in the development and progression of atherosclerosis Biochem Soc Trans 30 2002 163
4. A.M. Henney, P.R. Wakeley, and M.J. Davies Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization Proc Natl Acad Sci USA 88 1991 8154
5. Z.S. Galis, G.K. Sukhova, and M. Lark Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493
6. G.T. Jones, G.P. Tarr, and L.V. Phillips Active matrix metalloproteinases 3 and 9 are independently associated with coronary artery in-stent restenosis Atherosclerosis 207 2009 603
7. S. Ye, P. Eriksson, A. Hamsten, and M. Kurkinen Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression J Biol Chem 271 1996 13055
8. T.L. Medley, B.A. Kingwel, and C.D. Gatzka Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression Circ Res 92 2003 1254
9. S. Ye Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome Cardiovasc Res 69 2006 636
10. A. Samnegard, A. Silveira, and P. Lundman Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction J Int Med 258 2005 411
11. M. Terashima, H. Akita, and K. Kanazawa Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction Circulation 99 1999 2717
12. S. Beyzade, S. Zhang, and Y. Wong Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction J Am Coll Cardiol 41 2003 2130
13. S.E. Humphries, S. Martin, and J. Cooper Interaction between smoking and the stromelysin-1 (MMP3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men Ann Hum Genet 66 2002 343
14. N. Lamblin, C. Bauters, and X. Hermant Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease J Am Coll Cardiol 40 2002 43
15. S. Humphries, C. Bauters, and A. Meirhaeghe P. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis Eur Heart J 23 2002 721
16. R. Rauramaa, S.B. Vaisanen, and L.A. Luong Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis Arterioscler Thromb Vasc Biol 20 2000 2657
17. T. Djurić, M. Zivković, and D. Radak Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis Clin. Biochem 41 2008 1326
18. T. Rundek, M.S. Elkind, and J. Pittman Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: The Northern Manhattan Prospective Cohort Study Stroke 33 2002 1420
19. Q.J. Chen, L. Lu, and W.H. Peng Polymorphisms of MMP-3 and TIMP-4 genes affect angiographic coronary plaque progression in non-diabetic and type 2 diabetic patients Clin Chim Acta 405 2009 97
20. P. Hoppmann, W. Koch, and Schomig The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions Eur Heart J 25 2004 335
21. P.G. McGlinchey, M.S. Spence, and C.C. Patterson The matrix metalloproteinase-3 (MMP-3) 5A/6A promoter polymorphism is not associated with ischaemic heart disease: Analysis employing a family based approach Dis Markers 20 2004 289
22. W. Koch, A. de Waha, and P. Hoppmann Haplotype and 5A/6A polymorphism of the matrix metalloproteinase -3 gene in coronary disease: Case-control study and meta-analysis Atherosclerosis 208 2010 171
23. K.E. Porter, J. Naik, and N.A. Turner Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration J Vasc Surg 36 2002 150
24. H.A. Madi, K. Riches, and P. Warburton Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and type 2 diabetic patients Am J Physiol Cell Physiol 297 2009 C1307
25. E.J. Jacobsen, M.A. Mitchell, and S.K. Hendges Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors J Med Chem 42 1999 1525
26. J.P. Beilby, C.M. Chapman, and L.J. Palmer Stromelysin-1 (MMP-3) gene 5A/6A promoter polymorphism is associated with blood pressure in a community population J Hypertens 23 2005 537
27. J. Deguara, K.G. Burnand, and J. Berg An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms Hum Mol Genet 16 2007 3002
28. A. Maqbool, N.A. Turner, and S. Galloway The -1562C/T MMP-9 promoter polymorphism does not predict MMP-9 expression levels or invasive capacity in saphenous vein smooth muscle cells cultured from different patients Atherosclerosis 207 2009 458
29. T.W. James, R. Wagner, and L.A. White Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle-derived cell line J Cell Physiol 157 1993 426
30. C. Lovdahl, J. Thyberg, and B. Cercek Antisense oligonucleotides to stromelysin mRNA inhibit injury-induced proliferation of arterial smooth muscle cells Histol Histopathol 14 1999 1101
31. K. Kallenbach, R. Salcher, and Heim Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3 J Vasc Surg 49 2009 750
32. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls Nature 447 2007 661
33. P.Y. Liu, Y.H. Li, and S.H. Chan Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome Am J Cardiol 98 2006 1012
34. M. Seifi, S. Fallah, and M. Firoozrai Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis Arch Med Res 40 2009 600
35. N.A. Turner, K.T. Hall, and S.G. Ball Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells Atherosclerosis 193 2007 36
36. V. Souslova, P.A. Townsend, and J. Mann Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFκB PLoS ONE 5 2010 e9902
37. B. Gao, and Z.C. Li Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16 2004 536
38. A.J. White, S.J. Duffy, and A.S. Walton Matrix metalloproteinase-3 and coronary remodelling: Implications for unstable coronary disease Cardiovasc Res 75 2007 813
39. K.K.S.V.K. Shah, M.R. Mashru, and S.L. Soneji Matrix metalloproteinase-3 (MMP-3) -1612 5A/6A promoter polymorphism in coronary artery disease in Indian population Indian J Clin Biochem 25 2010 133
40. R.C. Borghaei, G. Gorski, and M. Javadi NF-κB and ZBP-89 regulate MMP-3 expression via a polymorphic site in the promoter Biochem Biophys Res Commun 382 2009 269